Article
Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.
Liver international : official journal of the International Association for the Study of the Liver - 1 Aug 2009
Alvarez-Uria Gerardo, Day Jeremy N, Nasir Anisa J, Russell Susan K, Vilar Francisco Javier
Abstract excerpt
BACKGROUND: Genotype 2/3 hepatitis C virus (HCV) has a good response to treatment with peginterferon and ribavirin. Patients with psychiatric disorders and injecting drug users (IDUs) are considered 'difficult to treat' and are often excluded from treatment despite the lack of evidence supporting this decision. AIMS: To investigate the outcome and factors associated with treatment failure in these groups....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.